An intermediate effect size variant in UMOD confers risk for chronic kidney disease
View ORCID ProfileEric Olinger, Céline Schaeffer, Kendrah Kidd, Yurong Cheng, Inès Dufour, Guglielmo Schiano, Holly Mabillard, Elena Pasqualetto, Elhussein A. E. Elhassan, Patrick Hofmann, Daniel G. Fuster, Andreas D. Kistler, Peter J. Conlon, Ian J. Wilson, Stanislav Kmoch, Genomics England Research Consortium, Kai-Uwe Eckardt, Anthony J. Bleyer Sr., Anna Köttgen, Michael Wiesener, View ORCID ProfileJohn A. Sayer, Luca Rampoldi, Olivier Devuyst
doi: https://doi.org/10.1101/2021.09.27.21263789
Eric Olinger
1Institute of Physiology, University of Zurich, CH-8057 Zurich, Switzerland
2Translational and Clinical Research Institute, Newcastle University, NE1 3BZ Newcastle upon Tyne, United Kingdom
Céline Schaeffer
3Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Kendrah Kidd
4Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, 27101 NC
5Department of Paediatrics and Adolescent Medicine, Charles University, 128 08 Prague, Czech Republic
Yurong Cheng
6Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center - University of Freiburg, D 79106 Freiburg, Germany
16Faculty of Biology, University of Freiburg, Freiburg, Germany
Inès Dufour
1Institute of Physiology, University of Zurich, CH-8057 Zurich, Switzerland
7Division of Nephrology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium
Guglielmo Schiano
1Institute of Physiology, University of Zurich, CH-8057 Zurich, Switzerland
Holly Mabillard
8Renal Services, Newcastle Upon Tyne Hospitals National Health Service Trust, NE7 7DN, Newcastle upon Tyne, UK
Elena Pasqualetto
3Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Elhussein A. E. Elhassan
9Division of Nephrology, Beaumont General Hospital, 1297 Dublin, Republic of Ireland and Department of Medicine, Royal College of Surgeons in Ireland
Patrick Hofmann
1Institute of Physiology, University of Zurich, CH-8057 Zurich, Switzerland
Daniel G. Fuster
10Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland
Andreas D. Kistler
11Department of Medicine, Cantonal Hospital Frauenfeld, 8501 Frauenfeld, Switzerland
Peter J. Conlon
9Division of Nephrology, Beaumont General Hospital, 1297 Dublin, Republic of Ireland and Department of Medicine, Royal College of Surgeons in Ireland
Ian J. Wilson
12Biosciences Institute, Newcastle University, Central Parkway, NE1 3BZ Newcastle upon Tyne, United Kingdom
Stanislav Kmoch
4Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, 27101 NC
5Department of Paediatrics and Adolescent Medicine, Charles University, 128 08 Prague, Czech Republic
Kai-Uwe Eckardt
13Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany
14Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
Anthony J. Bleyer Sr.
4Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, 27101 NC
5Department of Paediatrics and Adolescent Medicine, Charles University, 128 08 Prague, Czech Republic
Anna Köttgen
6Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center - University of Freiburg, D 79106 Freiburg, Germany
17CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany
Michael Wiesener
14Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
John A. Sayer
2Translational and Clinical Research Institute, Newcastle University, NE1 3BZ Newcastle upon Tyne, United Kingdom
8Renal Services, Newcastle Upon Tyne Hospitals National Health Service Trust, NE7 7DN, Newcastle upon Tyne, UK
15NIHR Newcastle Biomedical Research Centre, NE4 5PL Newcastle upon Tyne, United Kingdom
Luca Rampoldi
3Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Olivier Devuyst
1Institute of Physiology, University of Zurich, CH-8057 Zurich, Switzerland
7Division of Nephrology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data that support the findings of this study are available from the article and the supplementary files, through The Human Gene Mutation Database at http://www.hgmd.cf.ac.uk/ac/index.php and PubMed at https://pubmed.ncbi.nlm.nih.gov. Data presented here were derived from the following resources available in the public domain: The Genome Aggregation Database v2.1.1 (https://gnomad.broadinstitute.org/) and Ensembl (release 100): (https://www.ensembl.org/index.html).
Posted October 02, 2021.
An intermediate effect size variant in UMOD confers risk for chronic kidney disease
Eric Olinger, Céline Schaeffer, Kendrah Kidd, Yurong Cheng, Inès Dufour, Guglielmo Schiano, Holly Mabillard, Elena Pasqualetto, Elhussein A. E. Elhassan, Patrick Hofmann, Daniel G. Fuster, Andreas D. Kistler, Peter J. Conlon, Ian J. Wilson, Stanislav Kmoch, Genomics England Research Consortium, Kai-Uwe Eckardt, Anthony J. Bleyer Sr., Anna Köttgen, Michael Wiesener, John A. Sayer, Luca Rampoldi, Olivier Devuyst
medRxiv 2021.09.27.21263789; doi: https://doi.org/10.1101/2021.09.27.21263789
An intermediate effect size variant in UMOD confers risk for chronic kidney disease
Eric Olinger, Céline Schaeffer, Kendrah Kidd, Yurong Cheng, Inès Dufour, Guglielmo Schiano, Holly Mabillard, Elena Pasqualetto, Elhussein A. E. Elhassan, Patrick Hofmann, Daniel G. Fuster, Andreas D. Kistler, Peter J. Conlon, Ian J. Wilson, Stanislav Kmoch, Genomics England Research Consortium, Kai-Uwe Eckardt, Anthony J. Bleyer Sr., Anna Köttgen, Michael Wiesener, John A. Sayer, Luca Rampoldi, Olivier Devuyst
medRxiv 2021.09.27.21263789; doi: https://doi.org/10.1101/2021.09.27.21263789
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3623)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2329)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1237)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)